1887

Abstract

Our objective was to estimate the burden of fungal disease on the island of Ireland, as part of a coordinated project estimating the global burden. Published epidemiology data describing fungal infection in Ireland were identified. Population and underlying disease data were collected for 2010 and a structured set of assumptions were applied to estimate burden of fungal disease based on immunosuppression, chronic disease, and other demographic information indicating predisposition to fungal infection. From Ireland’s population of 6.4 million, we estimate 117 000 patients develop significant fungal disease each year. By far the most common fungal disease is recurrent vaginitis, with an estimated 95 000 episodes annually (3000 per 100 000 women). Other fungal diseases which may be less well recognized are severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis, with estimated episodes per year of 11 700 and 9000, respectively (182 and 140 per 100 000 population, respectively). The model also estimates 450 episodes of invasive aspergillosis, 200 of chronic pulmonary aspergillosis, 600 of oesophageal candidiasis and 450 of candidaemia per year (7, 3, 9 and 6 episodes per 100 000 population, respectively). This is, we believe, the first attempt to estimate the burden of fungal disease in our population and provides a basis for estimating its impact on human health and resource use.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000020
2015-04-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/64/4/423.html?itemId=/content/journal/jmm/10.1099/jmm.0.000020&mimeType=html&fmt=ahah

References

  1. Baxter C. G., Dunn G., Jones A. M., Webb K., Gore R., Richardson M. D., Denning D. W. 2013; Novel immunologic classification of aspergillosis in adult cystic fibrosis. J Allergy Clin Immunol 132:560–566, e10 [View Article][PubMed]
    [Google Scholar]
  2. Brown G. D., Denning D. W., Gow N. A. R., Levitz S., Netea M., White T. 2012; Human fungal infections: the hidden killers. Sci Transl Med 4:165rv13 [View Article][PubMed]
    [Google Scholar]
  3. Buchacz K., Baker R. K., Palella F. J. Jr, Chmiel J. S., Lichtenstein K. A., Novak R. M., Wood K. C., Brooks J. T. HOPS Investigators 2010; AIDS – defining opportunistic illnesses in US patients, 1994–2007: a cohort study. AIDS 24:1549–1559 [View Article][PubMed]
    [Google Scholar]
  4. Coyle P. V., McCaughey C., Nager A., McKenna J., O’Neill H., Feeney S. A., Fairley D., Watt A., Cox C., Curran T. 2012; Rising incidence of Pneumocystis jirovecii pneumonia suggests iatrogenic exposure of immune-compromised patients may be becoming a significant problem. J Med Microbiol 61:1009–1015 [View Article][PubMed]
    [Google Scholar]
  5. Cystic Fibrosis Registry of Ireland (2011). Annual Report. Dublin: Cystic Fibrosis Registry of Ireland http://www.cfri.ie/docs/annual_reports/CFRI2011.pdf
  6. Denning D. W., O’Driscoll B. R., Hogaboam C. M., Bowyer P., Niven R. M. 2006; The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 27:615–626 [View Article][PubMed]
    [Google Scholar]
  7. Denning D. W., Pleuvry A., Cole D. C. 2011; Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ 89:864–872 [View Article][PubMed]
    [Google Scholar]
  8. Denning D. W., Pleuvry A., Cole D. C. 2013; Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol 51:361–370 [View Article][PubMed]
    [Google Scholar]
  9. Foxman B., Muraglia R., Dietz J. P., Sobel J. D., Wagner J. 2013; Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis 17:340–345 [View Article][PubMed]
    [Google Scholar]
  10. Guinea J., Torres-Narbona M., Gijón P., Muñoz P., Pozo F., Peláez T., de Miguel J., Bouza E. 2010; Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 16:870–877 [View Article][PubMed]
    [Google Scholar]
  11. Health Protection Surveillance Centre (HPSC) (2011). HIV in Ireland Report 2011. 25–27 Dublin: Health Protection Surveillance Centre http://www.hpsc.ie/A-Z/HIVSTIs/HIVandAIDS/SurveillanceReports/2011Reports/File,13068,en.pdf
  12. HPA Northern Ireland (2011). Health Protection Report 2011, vol. 5 no. 37. Belfast: Health Promotion Agency for Northern Ireland http://webarchive.nationalarchives.gov.uk/20140714084352/
  13. López-Campos Bodineau J. L., Fernández Guerra J., Lara Blanquer A., Perea-Milla López E., Moreno L., Cebrián Gallardo J. J., García Jiménez J. M. 2002; [Analysis of admissions for chronic obstructive pulmonary disease in Andalusia in 2000]. Arch Bronconeumol 38:473–478 (in Spanish) [PubMed] [CrossRef]
    [Google Scholar]
  14. Lortholary O., Gangneux J. P., Sitbon K., Lebeau B., de Monbrison F., Le Strat Y., Coignard B., Dromer F., Bretagne S. French Mycosis Study Group 2011; Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007). Clin Microbiol Infect 17:1882–1889 [View Article][PubMed]
    [Google Scholar]
  15. Mastella G., Rainisio M., Harms H. K., Hodson M. E., Koch C., Navarro J., Strandvik B., McKenzie S. G. Epidemiologic Registry of Cystic Fibrosis 2000; Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Eur Respir J 16:464–471 [View Article][PubMed]
    [Google Scholar]
  16. Matee M. I., Scheutz F., Moshy J. 2000; Occurrence of oral lesions in relation to clinical and immunological status among HIV-infected adult Tanzanians. Oral Dis 6:106–111 [View Article][PubMed]
    [Google Scholar]
  17. Montravers P., Mira J. P., Gangneux J. P., Leroy O., Lortholary O. AmarCand Study Group 2011; A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect 17:1061–1067 [View Article][PubMed]
    [Google Scholar]
  18. Pappas P. G., Alexander B. D., Andes D. R., Hadley S., Kauffman C. A., Freifeld A., Anaissie E. J., Brumble L. M., Herwaldt L. et al. 2010; Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 50:1101–1111 [View Article][PubMed]
    [Google Scholar]
  19. Prospectus (2009). Towards Excellence in Critical Care. Review of Adult Critical Care Services in the Republic of Ireland. Dublin: Prospectus Management Services http://www.hse.ie/eng/about/Who/clinical/natclinprog/criticalcareprogramme/critcarrep09.pdf
  20. Public Health Agency (HSC) (2011). HIV and STI Surveillance in Northern Ireland 2011. An Analysis of Data for the Calendar Year 2010. Public Health Agency. Belfast: Public Health Agency http://www.publichealth.hscni.net/sites/default/files/HIV_and_STI_Report_12_2011.pdf
  21. Smith N. L., Denning D. W. 2011; Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur Respir J 37:865–872 [View Article][PubMed]
    [Google Scholar]
  22. Smith E., Orholm M. 1990; Trends and patterns of opportunistic diseases in Danish AIDS patients 1980–1990. Scand J Infect Dis 22:665–672 [View Article][PubMed]
    [Google Scholar]
  23. Sobel J. D. 2007; Vulvovaginal candidosis. Lancet 369:1961–1971 [View Article][PubMed]
    [Google Scholar]
  24. UK Cystic Fibrosis Registry (2011). Annual Data Report. Bromley: Cystic Fibrosis Trust https://www.cysticfibrosis.org.uk/.../CR_Annual_Data_Report_2011_Jan_13. pdf
  25. WHO Report (2009).People living with HIV. http://apps.who.int/ghodata/?vid=22100
  26. Zilberberg M. D., Shorr A. F., Kollef M. H. 2008; Secular trends in candidemia-related hospitalization in the United States, 2000–2005. Infect Control Hosp Epidemiol 29:978–980 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000020
Loading
/content/journal/jmm/10.1099/jmm.0.000020
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error